A daily dose of self-care can go a long way

Making time for yourself is essential for everyone, but especially for people living with hereditary angioedema (HAE) and their care partners. Self-care is a way to invest in your overall well-being and can be as simple as engaging in a hobby or taking a minute to relax with your favorite beverage.

Prioritize yourself today by exploring the activities below. These activities are offered as suggestions and should not be taken as medical advice. As with any new activity, check with your healthcare provider before you begin to confirm that it is appropriate for you.

The self-care wheel

1-minute breathing exercise

3-minute breathing exercise

Everyday inspiration

The self-care wheel

Self-care looks a little different for everyone

Below are a few different ways to help you get started incorporating self-care into your life.

Ask for help

Practice journaling

Lend a hand

Connect with nature

Celebrate what brings you joy

Trust your instinct

Identify stress triggers

Chase your dreams

- Michelle, a mother and care provider to 2 adult children living with HAE

INDICATION AND IMPORTANT
SAFETY INFORMATION

WHAT IS ORLADEYO® (berotralstat)?

ORLADEYO (or-luh-DAY-oh) is a prescription medicine used to prevent attacks of hereditary angioedema (HAE) in adults and children 12 years of age and older. It is not known if ORLADEYO is safe and effective in children under 12 years of age. It is not known if ORLADEYO is safe and effective to treat an acute HAE attack, therefore ORLADEYO should not be used to treat an acute HAE attack.

IMPORTANT SAFETY INFORMATION

Before taking ORLADEYO, tell your healthcare provider about all of your medical conditions, including if you

have liver problems or are on kidney dialysis.
are pregnant or planning to become pregnant. It is not known if ORLADEYO can harm your unborn baby.

INDICATION AND IMPORTANT SAFETY INFORMATION

WHAT IS ORLADEYO® (berotralstat)?

It is not known if ORLADEYO is safe and effective to treat an acute HAE attack, therefore ORLADEYO should not be used to treat an acute HAE attack.

Do not take more than one capsule of ORLADEYO per day because extra doses can cause heart rhythm problems.

IMPORTANT SAFETY INFORMATION

Before taking ORLADEYO, tell your healthcare provider about all of your medical conditions, including if you

have liver problems or are on kidney dialysis.
are pregnant or planning to become pregnant. It is not known if ORLADEYO can harm your unborn baby.
are breastfeeding or plan to breastfeed. It is not known if ORLADEYO passes into your breastmilk. Talk to your healthcare provider about the best way to feed your baby while taking ORLADEYO.

Tell your healthcare provider about all of the medicines you take, including other medicines for HAE, prescription and over-the-counter medicines, vitamins, and herbal supplements.

Taking ORLADEYO with certain other medicines may affect the way other medicines work and other medicines may affect how ORLADEYO works.

Know the medicines you take and keep a list of them to show your healthcare provider and pharmacist when you get a new medicine.

What are the possible side effects of ORLADEYO?

Taking more than one capsule of ORLADEYO per day may cause serious side effects, including heart rhythm problems. A heart rhythm problem called QT prolongation can happen in people who take more than one capsule of ORLADEYO per day. This condition can cause an abnormal heartbeat. Do not take more than one capsule of ORLADEYO per day.

The most common side effects of ORLADEYO include abdominal pain, vomiting, diarrhea, back pain, and heartburn. These are not all of the possible side effects of ORLADEYO. For more information, ask your healthcare provider or pharmacist.

Talk to your healthcare provider for medical advice about side effects.

You are encouraged to report side effects of prescription drugs to BioCryst Pharmaceuticals, Inc at 1-833-633-2279 or to the FDA at www.fda.gov/medwatch or 1-800-FDA-1088.

For more information, please see the full Prescribing Information including the Patient Information.